Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by HENNEMAN JOHN B III

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
APREAprea Therapeutics, Inc.HENNEMAN JOHN B IIIDirectorMar 13, 2024Buy$7.296,86050,0098,139Mar 14, 2024, 08:52 PM
RCMR1 RCM Inc. /DEHENNEMAN JOHN B IIIDirectorAug 08, 2023Sale$9.89100,000989,150122,114Aug 09, 2023, 04:36 PM
SPNESeaSpine Holdings CorpHENNEMAN JOHN B IIIDirectorAug 05, 2020Sale$15.0010,000150,00060,458Aug 05, 2020, 07:39 PM
APREAprea Therapeutics, Inc.HENNEMAN JOHN B IIIDirectorOct 07, 2019Buy$15.005,00075,0005,000Oct 07, 2019, 07:23 PM
(NLNK)NEWLINK GENETICS CORPHENNEMAN JOHN B IIIChief Administrative OfficerOct 01, 2018Option Exercise$2.282,4845,66455,052Oct 02, 2018, 05:22 PM
SPNESeaSpine Holdings CorpHENNEMAN JOHN B IIIDirectorAug 27, 2018Sale$14.724,56467,18260,144Aug 29, 2018, 06:03 PM
SPNESeaSpine Holdings CorpHENNEMAN JOHN B IIIDirectorAug 28, 2018Sale$14.652,02929,72558,115Aug 29, 2018, 06:03 PM
SPNESeaSpine Holdings CorpHENNEMAN JOHN B IIIDirectorAug 29, 2018Sale$14.653,40749,91354,708Aug 29, 2018, 06:03 PM
SPNESeaSpine Holdings CorpHENNEMAN JOHN B IIIDirectorJun 13, 2018Option Exercise$12.4417,398216,43164,708Jun 13, 2018, 07:50 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerJan 02, 2018Option Exercise$8.471641,38958,859Jan 04, 2018, 07:01 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerJan 04, 2018Option Exercise$10.061,32313,30957,536Jan 04, 2018, 07:01 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerOct 01, 2017Option Exercise$10.182,78928,39256,544Oct 02, 2017, 07:08 AM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerJan 03, 2017Option Exercise$10.281641,68659,935Jan 05, 2017, 06:29 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerJan 04, 2017Option Exercise$11.041,32314,60658,612Jan 05, 2017, 06:29 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerOct 01, 2016Option Exercise$15.022,78941,89160,099Oct 04, 2016, 05:52 PM
ACHIAccretive Health, Inc.HENNEMAN JOHN B IIIDirectorAug 16, 2016Buy$1.8050,00090,09750,000Aug 17, 2016, 05:25 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerJan 05, 2016Sale$35.741756,25562,316Jan 06, 2016, 06:51 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerOct 01, 2015Option Exercise$35.324,199148,30946,290Oct 05, 2015, 05:26 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerMay 14, 2015Buy$37.303,000111,90050,489May 14, 2015, 04:57 PM
NLNKNEWLINK GENETICS CORPHENNEMAN JOHN B IIIEVP, Chief Financial OfficerNov 25, 2014Buy$34.355,000171,75045,789Nov 25, 2014, 05:16 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, CAOAug 25, 2014Sale$50.1220,0001,002,33834,159Aug 26, 2014, 04:00 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, CAOMay 23, 2014Option Exercise$44.8214,299640,88154,159May 27, 2014, 04:05 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, Finance & Admin, CFOMar 25, 2014Option Exercise$45.771,26057,67068,458Mar 26, 2014, 04:22 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, Finance & Admin, CFOMar 10, 2014Sale$49.0010,000490,00053,611Mar 12, 2014, 04:25 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, Finance & Admin, CFOFeb 27, 2014Sale$46.075,000230,35563,611Feb 28, 2014, 04:07 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, Finance & Admin, CFODec 13, 2013Option Exercise$45.664,058185,28868,611Dec 16, 2013, 04:18 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIICorpVP, Finance & Admin, CFOAug 19, 2013Sale$42.0830,0001,262,29572,669Aug 20, 2013, 04:02 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOAug 10, 2012Sale$39.403,000118,20064,542Aug 13, 2012, 04:07 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOApr 27, 2012Sale$38.003,000114,00067,542Apr 30, 2012, 05:30 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOApr 26, 2012Sale$36.002,00072,00070,542Apr 30, 2012, 05:30 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOFeb 22, 2012Option Exercise$30.862,13265,79472,542Feb 23, 2012, 04:13 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOMay 03, 2011Sale$51.733,855199,40368,294May 04, 2011, 05:39 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOMar 08, 2011Sale$49.3810,000493,832110,656Mar 09, 2011, 04:54 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFOJan 03, 2011Option Exercise$47.301,26659,882120,656Jan 04, 2011, 04:43 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFODec 16, 2010Option Exercise$47.8429,0671,390,565118,067Dec 16, 2010, 04:16 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFODec 07, 2010Sale$47.465,324252,67784,424Dec 08, 2010, 04:38 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFONov 02, 2010Option Exercise$36.59141,2185,167,315160,357Nov 04, 2010, 04:16 PM
IARTINTEGRA LIFESCIENCES HOLDINGS CORPHENNEMAN JOHN B IIIEVP, Finance & Admin & CFONov 03, 2010Option Exercise$36.6058,7822,151,662119,139Nov 04, 2010, 04:16 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe